Nevertheless , thus far, the particular Iodine-131 conjugated Tumor Necrosis Targeting monoclonal antibody (TNT-3), licensed simply by Peregrine Pharmaceutical drugs reached the clinical trials just for therapeutic employ [13, 21]
Nevertheless , thus far, the particular Iodine-131 conjugated Tumor Necrosis Targeting monoclonal antibody (TNT-3), licensed simply by Peregrine Pharmaceutical drugs reached the clinical trials just… Read More »Nevertheless , thus far, the particular Iodine-131 conjugated Tumor Necrosis Targeting monoclonal antibody (TNT-3), licensed simply by Peregrine Pharmaceutical drugs reached the clinical trials just for therapeutic employ [13, 21]